FDA Inspection 629452 — Penn Medicine Lancaster General Hospital
The FDA completed an inspection of Penn Medicine Lancaster General Hospital on Nov 19, 2009 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 19, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)